The latest cancer drugs news
Browsing: Cancer Drug News
FDA grants accelerated approval to linvoseltamab-gcpt for relapsed or refractory multiple myeloma
On July 2, 2025, the Food and Drug Administration granted accelerated approval to linvoseltamab-gcpt, a…
FDA grants accelerated approval to sunvozertinib for metastatic non-small cell lung cancer with EGFR exon 20 insertion mutations
On July 2, 2025, the Food and Drug Administration granted accelerated approval to sunvozertinib Pharmaceutical…
FDA approves tafasitamab-cxix for relapsed or refractory follicular lymphoma
On June 18, 2025, the Food and Drug Administration approved tafasitamab-cxix with lenalidomide and rituximab…
Fixed-duration acalabrutinib-based regimens approved in EU for patients with chronic lymphocytic leukaemia in the 1st-line setting
A fixed-duration regimen of acalabrutinib in combination with venetoclax, with or without obinutuzumab, has been…
Thousands of blood cancer patients could benefit from new drug combination
Thousands of patients with a common type of blood cancer could benefit from a new…
ASCO 2025: Experimental Drug Development Centre announces the presentation of updated data from the phase 1 study of antibody-drug conjugate EBC-129
The Ental Drug Development Centre (EDDC), Singapore’s national platform for drug discovery and development, has…
New method of taxol production has the potential to greatly reduce the cost
Taxol is one of the most commonly prescribed chemotherapy drugs for breast, ovarian, cervical, and…
Scientists call into question safety of potential new anticancer treatment
Scientists have discovered that a promising new anticancer medicine currently in development could be made…
Scientific breakthrough: We can now halve the price of costly cancer drug
Taxol is one of the most commonly prescribed chemotherapy drugs for breast, ovarian, cervical and…
Daratumumab may help cancer patients with low physical function to live longer, study finds
How cancer patients relying on daratumab feel physically before starting the therapy can predict how long…